Jennifer Ruddock | Senior Vice President, IR |
Howard Robin | President and CEO |
Gil Labrucherie | Chief Financial Officer |
Dr. Steve Doberstein | Chief R&D Officer |
Dr. Jonathan Zalevsky | Chief Scientific Officer |
Dr. Mary Tagliaferri | Chief Medical Officer |
Chris Shibutani | Cowen |
Jessica Fye | J.P. Morgan |
Tyler Van Buren | Piper Jaffray |
Bert Hazlett | BTIG |
Arlinda Lee | Canaccord |
Andy Hsieh | William Blair |
Corey Davis | Seaport Global |
Debjit Chattopadhyay | H.C. Wainwright |
Good day, ladies and gentlemen. And welcome to the Nektar Therapeutics Q1 2018 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will be given at that time. [Operator Instructions] As a reminder, this conference call maybe recorded.